The U.S. Commodity Futures Trading Commission (CFTC) has taken a decisive step in its protracted legal battle with CME Group, filing a motion to completely dismiss the lawsuit that the exchange giant initiated against the regulator. The crux of the dispute is the CFTC's approval of Kalshi's launch of perpetual bitcoin futures contracts, which CME argues threatens its dominance in the derivatives market.
In my analysis, the regulator's key argument is CME's lack of a convincing evidentiary basis regarding actual harm from market competition. The CFTC directly points out that the plaintiff operates on hypothetical risks rather than actual losses. Moreover, the regulator highlights the obvious fact that CME possesses all the resources and licenses to launch a similar product on its own, without resorting to judicial blocking of competitors' innovations.
CME's own legal position deserves particular attention. The exchange insists that Kalshi's perpetual futures are, by their very nature, not futures but swaps, and therefore should be subject to a separate, stricter regulatory regime. However, such a classification looks like an attempt to use regulatory barriers to eliminate a competitor rather than to protect market interests. If CME truly believed in the "swap" nature of these contracts, its lawsuit would have been aimed at changing the rules, not at overturning a specific approval.
Judges will need to assess whether competitive pressure constitutes sufficient grounds for intervening in regulatory decisions. In my view, the CFTC's position appears legally more robust: precedents show that courts are extremely reluctant to recognize "harm" from fair competition when the plaintiff has alternative paths for business development. The ruling in this case could become an important marker for the entire crypto derivatives industry, determining how freely new platforms can introduce innovative products without regard for the interests of traditional exchange monopolists.
My expert conclusion: this lawsuit is a classic example of how established players attempt to slow down progress through legal mechanisms. The perpetual futures market has long been a global standard, and CME's attempts to block its legalization in the U.S. look like an anachronism that is unlikely to find support in court.